Actavia Life Sciences, Inc. (RASP) 股价表现
查看Actavia Life Sciences, Inc.股价及公司表现,包括市值,涨跌幅,市盈率,以及历史及当前股价。
昨收 0.00
52周最高 0.00
今开 0.00
52周最低 0.00
振幅 0.00%
市盈率 0%
成交额
0.00
亿
市净率 -1.42%
换手率 0.00%
总市值
0.03亿
股息 0
总股本
7.71
亿
股息收益率 0%
每手股数 1
Actavia Life Sciences, Inc.公司介绍
Rasna Therapeutics, Inc. (OTC:RASP), a development stage biotechnology company focused on the development of cancer drugs, today announced the successful completion of its merger. Rasna Therapeutics, Inc. is a development stage biotechnology company focused primarily on the development of drug candidates for leukemia and lymphoma. Abnormal epigenetic modification is recognized to play an important role in the pathogenesis of acute myeloid leukemia (AML), leading to silencing of genes involved in tumor suppression and cellular reproduction. Rasna's focus on inhibition of lysine specific demethylase-1 (LSD1), an enzyme involved in epigenetic control, represents a promising and novel approach towards AML. Rasna has developed novel irreversible and reversible LSD1 regulators that have shown appropriate effects on the LSD1 gene in-vitro and in IND-enabling pre-clinical studies.